+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer



Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer



European Journal of Cardio-Thoracic Surgery 45(2): 262-267



The clinical course from recurrence to cancer-related death after curative resection has not been clearly elucidated in non-small-cell lung cancer (NSCLC). This study examined the clinical outcomes after postoperative recurrence in patients with completely resected Stage I NSCLC. This study included patients who had recurrence after complete resection for pathological Stage I NSCLC between 2003 and 2009. Clinical data evaluated in this study included the diagnostic process of recurrence, recurrence pattern, treatment process and prognosis. A number of clinicopathological factors were analysed for post-recurrence survival by univariate and multivariate analyses. Seventy-two patients experienced recurrence during a median follow-up period of 37.5 months. Thirteen patients (18%) presented symptoms at the initial recurrence. Tumour markers, computed tomography (CT) and positron emission tomography/CT were chosen as the initial diagnostic tools and detected recurrences in 1 (1%), 51 (71%) and 7 (10%) patients, respectively. The mean recurrence-free interval (RFI) was 15.4 months (≤12 months in 34, >12 months in 38 patients). The patterns of recurrence were presented as loco-regional recurrence in 36 (50%) and distant metastasis in 36 patients (50%). Types of the initial treatment included operations in 28 (39%), chemotherapy and/or radiotherapy in 38 (53%) and radiofrequency ablation in 2 patients (3%). Four patients (6%) rejected treatment. Forty-three patients (62%) presented a good response to the initial treatment. Thirty-seven patients (51%) died, and the cause of death in all of these patients was cancer-related. The median survival duration after recurrence was 43.6 (1-136) months. Univariate analysis identified no recurrence of symptoms, a good response to treatment and a longer RFI as good prognostic factors, while a good response to treatment and a longer RFI were independent prognostic factors in multivariate analysis. Most postoperative recurrences were detected in an asymptomatic condition during the routine follow-up period, and a good response to initial treatment and a longer RFI were significant predictors of better post-recurrence survival in patients with completely resected Stage I NSCLC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036956558

Download citation: RISBibTeXText

PMID: 23811122

DOI: 10.1093/ejcts/ezt333


Related references

P1.08-066 Prognostic Factors of Post-Recurrence Survival in Patients with Completely Resected Stage Iii-N2 Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 12(1): S771-S772, 2017

Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 54(3): 554-559, 2018

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 64(3): 192-196, 2009

Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer. Yonago Acta Medica 60(4): 213-219, 2017

Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest 143(6): 1626-1634, 2013

Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 65(3): 241-245, 2010

Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected. Interactive Cardiovascular and Thoracic Surgery 21(1): 14-20, 2015

Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thoracic Cancer 6(1): 38-42, 2015

Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer. Journal of Thoracic Oncology 7(2): 397-405, 2012

The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer. Zhonghua Wai Ke Za Zhi 53(7): 502-507, 2015

Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer. Cancer Management and Research 5: 77-84, 2013

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival. Cancer Management and Research 5: 327-336, 2013

Biological prognostic factors for early stage completely resected non-small cell lung cancer. Journal of Surgical Oncology 74(1): 53-60, 2000

Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. Journal of Thoracic and Cardiovascular Surgery 132(3): 499-506, 2006

Post-operative adjuvant thoracic radiotherapy for patients with completely resected non-small cell lung cancer with nodal involvement: outcome and prognostic factors. British Journal of Radiology 77(913): 43-48, 2004